Bio-rad Laboratories, Inc. · NYSE:BIO
Norman D. Schwartz reported a 97.20% stake in Bio-rad Laboratories, Inc. (Schedule 13D/A)
Event Sep 25, 2025 · Filed Oct 30, 2025
Norman D. Schwartz reported a 97.20% stake in Bio-rad Laboratories, Inc., 4,929,036 shares, with active intent on Sep 25, 2025. Filed Oct 30, 2025 (Schedule 13D/A).
- Stake
- 97.20%
- Shares
- 4,929,036
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Norman D. Schwartz | 97.20% | 4,929,036 |
| Steven D. Schwartz | 80.80% | 4,098,294 |
| Blue Raven Partners, L.P. | 80.10% | 4,060,054 |
| Alice N. Schwartz Revocable Trust | 8.60% | 437,510 |
Source
Related
- Bio-rad Laboratories, Inc.
- Norman D. Schwartz
- Bio-rad Laboratories, Inc. shareholders
- Schedule 13D/A · Norman D. Schwartz · Oct 30, 2025
- Schedule 13D/A · Norman D. Schwartz · Oct 28, 2025
- Schedule 13D/A · Norman D. Schwartz · Oct 28, 2025
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G/A · First Eagle Investment Management, LLC · Aug 6, 2025
- Schedule 13D/A · Alice N. Schwartz · Jul 18, 2025
- Schedule 13G · First Eagle Investment Management, LLC · May 5, 2025